QA: Lipocine Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001535955_2019_Lipocine_Inc.pdf

Logs

Graph

Absolute values for 0001535955, Lipocine Inc

  xvar xval
0 AssetsCurrent 20,809,203
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 18,997
3 remainder_Assets 23,753
4 LiabilitiesCurrent 4,491,748
5 LiabilitiesNoncurrent 6,926,532
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 3,503,856
9 ResearchAndDevelopmentExpense 6,194,110
10 remainder_Expenses 700
11 remainder_Revenues 428,031
12 remainder_NetIncome -317,448
13 remainder_ComprehensiveNetIncome 3,749
  yvar yval
0 Assets 20,851,953
1 Liabilities 11,418,280
2 Expenses 9,698,666
3 Revenues 428,031
4 StockholdersEquity 9,433,673
5 NetIncome -9,588,083
6 ComprehensiveNetIncome -9,586,208
7 BaseVar 21,359,064
8 EconomicCapitalRatiobeforeLimitedLiability 0.680
9 EconomicCapitalRatio 2.04

Edgar->Model Mapping

Feature Distribution

Change over Time